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Oxidative stress has been postulated to play an important role in the pathogenesis of 
asthma; although a defect in antioxidant responses has been speculated to exacerbate 
asthma severity, this has been difficult to demonstrate with certainty. Nuclear erythroid 2 
p45-related factor 2 (Nrf2) is a redox-sensitive basic leucine zipper transcription factor 
that is involved in the transcriptional regulation of many antioxidant genes. We show that 
disruption of the 
 
Nrf2
 
 gene leads to severe allergen-driven airway inflammation and 
hyperresponsiveness in mice. Enhanced asthmatic response as a result of ovalbumin 
sensitization and challenge in 
 
Nrf2
 
-disrupted mice was associated with more pronounced 
mucus cell hyperplasia and infiltration of eosinophils into the lungs than seen in wild-type 
littermates. 
 
Nrf2
 
 disruption resulted in an increased expression of the T helper type 2 
cytokines interleukin (IL)-4 and IL-13 in bronchoalveolar lavage fluid and in splenocytes 
after allergen challenge. The enhanced severity of the asthmatic response from disruption of 
the Nrf2 pathway was a result of a lowered antioxidant status of the lungs caused by lower 
basal expression, as well as marked attenuation, of the transcriptional induction of multiple 
antioxidant genes. Our studies suggest that the responsiveness of 
 
Nrf2
 
-directed antioxidant 
pathways may act as a major determinant of susceptibility to allergen-mediated asthma.
 
Asthma is a complex inflammatory disorder
characterized by airway inflammation, inter-
mittent reversible airway obstruction, airway
hyperreactivity (AHR), excessive mucus pro-
duction, and elevated levels of immunoglobulin
E and Th2 cytokines (1–3). Studies have shown
that increases in reactive oxygen species (ROS)
that occur during asthma are associated with
damage to a wide range of biologic molecules in
the lung, and many observations suggest that
oxidative stress plays an important role in the
pathogenesis of asthma (4, 5).
Inflammatory cells in the airways and alveolar
spaces can release ROS/reactive nitrogen species
after phagocytosis of inhaled particles or after
their functional activation by various stimuli.
Granulocytic cells in bronchoalveolar lavage
(BAL), particularly eosinophils, are the major
source of ROS after antigen challenge in allergic
subjects (6). ROS-mediated activation of NF-
 
 
 
B
can induce the expression of proinflammatory
factors such as IL-8, TNF-
 
 
 
, regulated on ac-
tivation, normal T cells expressed and secreted
(RANTES), and eotaxin that further promotes
inflammatory cell infiltration into the lungs (7–
9). The direct mechanism by which ROS ex-
acerbates asthma might include effects on airway
smooth muscle and mucin secretion. ROS de-
creases 
 
 
 
-adrenergic function in lungs (10) and
also sensitizes airway muscle to acetylcholine-
induced contraction (11). The levels of nitric
oxide (NO) are elevated in the exhaled air of
patients with asthma and may contribute to air-
way edema and inflammation (12). The recent
finding that NO reduces the effect of 
 
 
 
-adren-
ergic signaling pathways may be a deleterious
effect of the elevated reactive nitrogen species
in asthma (13). A reaction between NO and
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O
 
2
 
 
 
 resulting in the formation of peroxinitrite anions
(ONOO
 
 
 
) induces airway hyperesponsiveness in guinea
pigs, inhibits pulmonary surfactant, and leads to membrane
lipid peroxidation and tyrosine- and mitogen-activated pro-
tein kinase activation, ultimately damaging pulmonary epi-
thelial cells (13–16).
Figure 1. Increased allergen-driven asthmatic inflammation in 
OVA-challenged Nrf2 /  mice. (A) Total and differential inflammatory 
cell populations in the BAL fluid of OVA- and saline-challenged Nrf2 /  
and Nrf2  /  mice (n   8). (B) First challenge with OVA. (C) Second challenge 
with OVA. (D and E) Third challenge with OVA. There was a progressive 
increase in the total number of inflammatory cells in the BAL fluid of both 
OVA-challenged Nrf2 /  and Nrf2 /  mice from the first to third challenges. 
However, the number of inflammatory cells in the BAL fluid of Nrf2 /  
OVA mice was significantly higher than in the BAL fluid of Nrf2 /  OVA 
mice, as well as the respective saline-challenged mice. The number of 
eosinophils, lymphocytes, neutrophils, and epithelial cells were signifi-
cantly (*) higher in the BAL fluid of Nrf2 /  OVA mice compared with 
Nrf2  /  OVA mice. Pretreatment with NAC significantly (*) reduced the 
inflammatory cells (F), predominantly eosinophils (G), in the BAL fluid of 
Nrf2 /  OVA mice (n   6). Data are mean   SEM. *, P   0.05. 
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An excess production of oxidants is kept to a minimum by
a well coordinated and efficient endogenous antioxidant de-
fense system that is both enzymatic and nonenzymatic in na-
ture. The enzymatic antioxidants include the families of su-
peroxide dismutase (SOD), catalase, glutathione peroxidase,
glutathione 
 
S
 
-transferase (GST), and thioredoxin. The non-
enzymatic category of antioxidant defenses includes glu-
tathione, ascorbate, 
 
 
 
-tocopherol, urate, bilirubin, and lipoic
acid (4, 17, 18). Individuals with asthma demonstrate de-
pressed levels of ascorbate and 
 
 
 
-tocopherol in BAL, dimin-
ished activities of superoxide dismutase, and elevated oxidized
GSH disulfide (GSSG)/GSH ratios, suggesting both increased
ROS/reactive nitrogen species and decreased antioxidant ca-
pacity (19). Interestingly, a recent study has indicated that
higher levels of serum antioxidants such as vitamin C and
 
 
 
-carotene were associated with a lower risk of asthma (20).
Although oxidative stress, which originates from infiltrat-
ing inflammatory cells, is suspected to be involved in the
pathogenesis of the disease, there is no conclusive experimen-
tal evidence to support the idea that defective antioxidant re-
sponses in lungs may lead to worsened asthma or exacerbate
airway inflammation and AHR. Critical host factors that pro-
tect the lungs against oxidative stress may either directly deter-
mine susceptibility to asthma or act as risk modifiers by inhib-
iting associated inflammation. Nuclear erythroid 2 p45 related
factor 2 (Nrf2) encodes a cap “n” collar basic leucine zipper
(b-ZIP) transcription factor, which detaches from its cytosolic
inhibitor (keap1), translocates to the nucleus, and binds to the
antioxidant response element (ARE) in the promoter of target
genes upon activation in response to oxidative stress, leading
to their transcriptional induction (21). The Nrf2-regulated
genes in the lungs include almost all of the relevant antioxi-
dants, such as 
 
heme oxygenase 1
 
 (
 
HO-1
 
), 
 
 
 
-glutamyl cysteine syn-
thase
 
, and several members of the GST family (21).
To test the hypothesis that deficiency in 
 
Nrf2
 
-mediated
antioxidant defenses plays a central role in pathogenesis of
asthma, we studied allergen-driven airway inflammation in
wild-type and 
 
Nrf2
 
-deficient mice. Our results show that
disruption of the 
 
Nrf2
 
 gene in mice leads to increased airway
inflammation, AHR, goblet cell hyperplasia, and an elevated
level of Th2 cytokines in the lungs in a model of allergen-
mediated asthma using OVA challenge.
 
RESULTS
BAL cell counts
 
The total number of inflammatory cells in the BAL fluid of all
OVA-challenged (first to third) 
 
Nrf2
 
-deficient mice (
 
Nrf2
 
 
 
/
 
 
 
OVA mice) was significantly higher than OVA-challenged
Figure 2. Increased infiltration of inflammatory cells into the 
lungs of OVA-challenged Nrf2 /  mice. Lung tissues from the saline- 
and OVA-challenged (third challenge) Nrf2 /  and Nrf2 /  mice (n   6) 
were stained with H&E and examined by light microscope (20 ). (A) OVA 
challenge caused a marked infiltration of inflammatory cells into the 
lungs of Nrf2 /  OVA compared with Nrf2  /  OVA mice. Immunohistochem-
ical staining showed the presence of numerous eosinophils around the 
blood vessels and airways (B) and in the parenchyma (C) of OVA-challenged 
(third challenge) Nrf2 /  compared with Nrf2  /  mice. The figure is 
representative of three experiments (n   6). AW, airways; BV, blood 
vessels. H&E staining of the lung sections from the saline-or NAC-
treated (7 d before first OVA challenge) Nrf2-deficient mice. The arrows 
indicate cells staining positively with anti-MBP antibody. (D) Widespread 
peribronchial and perivascular inflammatory infiltrates were observed in 
OVA-sensitized mice after antigen provocation (bottom right). Pretreat-
ment of Nrf2-deficient mice with NAC resulted in substantial reduction 
in the infiltration of inflammatory cells in the peribronchial and perivascular 
region (bottom left). 
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Nrf2
 
 wild-type mice (
 
Nrf2
 
 
 
/
 
 
 
 OVA mice) (P 
 
  
 
0.05; Fig. 1
A). The number of inflammatory cells in the BAL fluid of
 
Nrf2 /  OVA mice (third challenge) was 2.9-fold higher
(6.7   106 cells/ml BAL fluid) than its level (2.3   106 cells/ml
BAL fluid) in Nrf2 /  OVA mice. The increase in inflamma-
tion was progressive from the first to the third OVA chal-
lenge. A differential cell count analysis showed a significantly
higher number of eosinophils, lymphocytes, and neutrophils,
as well as epithelial cells, in the BAL fluid of Nrf2 /  OVA
mice (P   0.05; Fig. 1, B–E). 72 h after the third challenge,
there were 2.3-, 3-, 4.5-, 4.8-, and 8.5-fold more macro-
phages, eosinophils, epithelial cells, neutrophils, and lympho-
cytes, respectively, in the BAL fluid of Nrf2 /  OVA than
Nrf2 /  OVA mice (Fig. 1, D and E). Among the inflamma-
tory cell populations, eosinophils were the predominant cell
population, followed by macrophages, lymphocytes, and neu-
trophils, at each time point (Fig. 1, B–E).
Lung histopathology
There was a marked extravasation of inflammatory cells into
the lungs of Nrf2 /  OVA mice (third challenge) relative to
the mild cellular infiltration in the lungs of Nrf2 /  OVA
mice, as determined by staining of the lung sections with he-
matoxylin and eosin (H&E). Higher numbers of inflammatory
cells were observed in the perivascular, peribronchial, and pa-
renchymal tissues of the Nrf2 /  OVA mice compared with a
few inflammatory cell infiltrates in the Nrf2 /  OVA mice
(Fig. 2 A). Immunohistochemical staining with anti–major ba-
sophilic protein (MBP) antibody showed numerous eosino-
phils around the blood vessels and airways (Fig. 2 B) and in the
Figure 3. Increased oxidative stress markers, eotaxin, and enhanced 
activation of NF- B in the lungs of Nrf2 /  OVA mice. Increased 
levels of lipid hydroperoxides (A) and protein carbonyls (B) in the lungs of 
OVA-challenged Nrf2 /  mice. Values are mean   SEM. *, Significantly 
higher than the Nrf2 /  OVA mice (n   6). (C) Eotaxin level in the BAL 
fluid. When compared with OVA-challenged Nrf2 /  mice, the BAL eotaxin 
level was markedly higher in OVA-challenged (both first and third challenge) 
Nrf2 /  mice (P   0.05; n   6). (D–F) Activation of NF- B in the lungs. 
Western blot was used to determine the activation of p50 and p65 sub-
units of NF- B in the lungs (D). (lanes 1 and 2) Saline-challenged Nrf2 /  
and Nrf2–/– mice, respectively; (lanes 3 and 4) OVA-challenged Nrf2 /  and 
Nrf2–/– mice, respectively. (E) Quantification of p50 and p65 subunits of 
NF- B obtained in Western blots. Values are mean   SEM of three exper-
iments. (F) ELISA measurement of p65/Rel A subunit of NF- B using 
Mercury TransFactor kit. *, P   0.05 versus OVA-challenged Nrf2 wild-
type mice. Data are mean   SEM of three experiments.JEM VOL. 202, July 4, 2005 51
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parenchymal tissues (Fig. 2 C) of Nrf2 /  OVA mice com-
pared with Nrf2 /  OVA mice. These histological data are
consistent with the differential cell counts in the BAL fluid ob-
tained from the OVA-challenged Nrf2 /  and Nrf2 /  mice.
Intervention with N-acetyl L-cysteine (NAC)
To determine whether reducing the oxidative burden would
attenuate airway inflammation, we treated mice for 7 d with
NAC before the first OVA challenge. Histological analysis
showed widespread peribronchial and perivascular inflamma-
tory infiltrates in the OVA-challenged (first challenge)
Nrf2 /  mice when compared with the saline-challenged con-
trol mice. NAC-pretreated mice showed a marked reduction
in the infiltration of inflammatory cells in the peribronchiolar
and perivascular region (Fig. 2 D). Concomitant with histo-
logical assessment, airway inflammation was evaluated in the
BAL fluid. As expected, antigen-challenged Nrf2   /  mice
showed a marked increase in the total number of inflamma-
tory cells (21   104 cells/ml BAL fluid vs. 3.2   104 cells/ml
BAL fluid in saline group) in the BAL fluid 24 h after OVA
challenge (Fig. 1 F). Among the inflammatory cell population,
eosinophils were the predominant cells in the BAL fluid
(14.38   104 cells/ml BAL fluid) and were significantly di-
minished (7.8   104 cells/ml BAL fluid) by treatment with
NAC (P   0.05; Fig. 1 G) in the OVA-challenged Nrf2-defi-
cient mice. NAC treatment did not have any significant in-
hibitory effect on other cell types such as macrophages, neu-
trophils, lymphocytes, and epithelial cells 24 h after the first
OVA challenge. The total and differential cell counts observed
in saline-challenged mice treated with NAC did not differ
from counts obtained in saline-challenged untreated mice.
Increased level of oxidative stress markers, eotaxin, 
and enhanced activation of NF- B in the lungs of 
Nrf2 /  OVA mice
We measured the levels of lipid hydroperoxides and protein
carbonyls in the lungs as markers of oxidative stress. When
compared with OVA-challenged Nrf2 wild-type mice, there
was a significantly increased amount of lipid hydroperoxides
(11.3  g/mg protein vs. 19.4  g/mg protein; Fig. 3 A) and
protein carbonyls (165 nM/mg protein vs. 349 nM/mg pro-
tein; Fig. 3 B) in the lungs of Nrf2 /  OVA mice, suggesting
the occurrence of excessive oxidative stress in response to al-
lergen challenge (P   0.05).There was a significant increase
in the GSH level and GSH/GSSG ratio in the lungs of
Nrf2 /  OVA mice (first and third challenge) when com-
pared with the lungs of Nrf2 /  OVA mice (P   0.05; Fig.
S1, A and B, available at http://www.jem.org/cgi/content/
full/jem.20050538/DC1).
The eosinophil chemottractant eotaxin level in the BAL
fluid of first and third OVA-challenged Nrf2-deficient mice
was significantly higher when compared with its wild-type
counterpart (P   0.05; Fig. 3 C). A substantial increase in the
level of eotaxin was observed in the BAL fluid of third OVA-
challenged animals, which was concomitant with the increased
infiltration of eosinophils in the lungs (Fig. 2, B and C).
NF- B has been reported to be activated by oxidative
stress and also regulate eotaxin production (22). Therefore,
we determined the activation of NF- B in the lungs of
Nrf2 /  and Nrf2 /  mice by Western blot analysis with anti–
NF- B p65 and anti–NF- B p50 antibodies. Immunoblot
analysis showed significantly higher levels of both p65 and
p50 NF- B subunits in the lung nuclear extracts of Nrf2 / 
OVA mice than in the lung nuclear extracts of Nrf2 /  OVA
mice (P   0.05; Fig. 3, D and E). DNA binding activity assay
with a Mercury TransFactor ELISA kit showed the increased
binding of p65/Rel A subunit from the lung nuclear extracts
of Nrf2 /  OVA mice to an NF- B binding sequence com-
pared with its wild-type counterpart (Fig. 3 F).
Mucus cell hyperplasia
Periodic acid-Schiff (PAS) staining of lung sections showed a
marked increase in the mucus-producing granular goblet
cells in the proximal airways of Nrf2 /  OVA mice relative
to fewer purple-staining goblet cells in the Nrf2 /  OVA
mice after the third challenge (Fig. 4 A). There were no or
Figure 4. Nrf2-deficient mice show increased mucus cell hyperplasia 
in response to allergen challenge. (A) Lung sections (72 h after the final 
OVA challenge) stained with PAS. Shown are the purple staining epithelial 
cells (arrows) in the proximal airways of OVA-challenged mice and pro-
nounced mucus cell hyperplasia in Nrf2  /  OVA mice (40 ). (B) Percent-
age of airway epithelial cells positive for mucus glycoproteins by PAS 
staining. Lung sections from the Nrf2 /  OVA mice showed significantly 
higher numbers of PAS-positive cells than the lung sections from the
Nrf2  /  OVA mice (*, P   0.05). Data are mean   SEM.ROLE OF NRF2 IN ASTHMA | Rangasamy et al. 52
few PAS-positive cells in the proximal airways of saline-
challenged mice or in the distal airways (not depicted) of
both Nrf2 /  OVA and Nrf2 /  OVA mice. The percent-
age of airway epithelial cells staining for mucus glycoproteins
by PAS was significantly higher in the proximal airways of
Nrf2 /  OVA mice than in those of the Nrf2 /  OVA and
the respective saline-challenged mice (P   0.05; Fig. 4 B).
Airway responsiveness to acetylcholine
After systemic sensitization and challenges to OVA, airway re-
sponsiveness to acetylcholine aerosol was measured. In the ab-
sence of an acetylcholine challenge, no substantial differences
in baseline elastance (Fig. 5 A) and resistance (Fig. 5 B) were
observed in both saline- and OVA-challenged Nrf2 /  and
wild-type mice. However, 96 h after the third OVA chal-
lenge, the Nrf2 /  mice showed a significant increase in base-
line elastance (Fig. 5 C) and resistance (Fig. 5 D) to acetylcho-
line compared with the wild-type counterpart (P   0.05).
Cytokine levels in BAL fluid
Analysis of BAL fluid by ELISA showed a marked increase in
the levels of IL-4 (76 vs. 42 pg/ml BAL fluid) and IL-13
(154 vs. 72 pg/ml BAL fluid) in the Nrf2 /  OVA mice rel-
ative to the Nrf2 /  OVA mice. The levels of these cyto-
kines were very low in the BAL fluid of saline- treated con-
trol mice of both genotypes (Fig. 6, A and B).
Inflammatory cytokine response of the splenocytes
To determine whether enhanced Th2 cell secretion in
OVA-challenged mice was reflected at the level of systemic
sensitization, we isolated splenocytes from mice 48 h after
the second challenge and studied cytokine secretion in vitro
after culture with OVA or antibodies directed against CD3
and CD28. Table S1 (available at http://www.jem.org/cgi/
content/full/jem.20050538/DC1) shows the results from
these experiments, indicating that the production of IL-4
and IL-13 was consistently higher using splenocytes from
Nrf2 /  versus wild-type mice when stimulated ex vivo.
Recall production of IL-4 was generally low in these mice,
in keeping with prior experience with this strain. Enhanced
Figure 5. Nrf2-deficient mice show increased airway responsive-
ness to acetylcholine challenge. OVA-challenged Nrf2 /  and Nrf2 /  
mice (third challenge) were challenged with acetylcholine aerosol by 
nebulization with an Aeroneb Pro-nebulizer (n   7). Lung resistance and 
compliance were measured. The percent increase in elastance (E; panel C) 
and resistance (R; panel D) to acetylecholine challenge were significantly 
higher (*, P   0.05) in the Nrf2 /  OVA mice when compared with Nrf2 /  
OVA mice and the respective saline-challenged mice. However, no signifi-
cant difference in baseline elastance (A) and resistance (B) were observed 
in both the saline- and OVA-challenged Nrf2 /  and Nrf2 /  mice in the 
absence of acetylcholine challenge. Data are mean   SEM.
Figure 6. Th2 cytokine levels in the BAL fluid of Nrf2 /  and
Nrf2  /  mice challenged with OVA. BAL fluids collected 48 h after
the second OVA challenge were used for cytokine assays using ELISA. The 
amounts of both IL-4 (A) and IL-13 (B) were significantly higher 
(*, P   0.05) in the BAL fluid of Nrf2 /  OVA mice than in Nrf2  /  OVA 
mice (n   8). Data are mean   SEM.JEM VOL. 202, July 4, 2005 53
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Th2 cytokine production in these experiments could reflect
a direct repressive effect of Nrf2 on Th2 cytokine gene ex-
pression, or an indirect effect via regulation of the oxidant/
antioxidant balance. To distinguish between these possibili-
ties, we first isolated spleen CD4  cells from unchallenged
wild-type and Nrf2 /  mice and studied cytokine produc-
tion ex vivo. No significant differences (P   0.05) in IL-4 or
IL-13 secretion were observed in these experiments (Table
S2, available at http://www.jem.org/cgi/content/full/
jem.20050538/DC1). We determined whether Nrf2 could
directly regulate IL-4 or IL-13 gene expression or promoter
activity in transient transfection assays. Although overexpres-
sion of Nrf2 substantially increased the expression of its
known target genes glutathione cysteine ligase catalytic subunit
(GCLc) and NADPH:quinone oxidoreductase (NQO1), there
was no effect on IL-13 gene expression (Fig. S2, available
at http://www.jem.org/cgi/content/full/jem.20050538/
DC1). In parallel experiments, we found that overexpressed
Nrf2 did not affect transcription driven by the IL-4 or IL-3
promoters (Fig. S3). Thus, we concluded from these data
that Nrf2 deficiency indirectly enhanced Th2 cytokine pro-
duction via regulation of the oxidant/antioxidant balance.
Activation of Nrf2 in the lungs of Nrf2 /  mice
Electrophoretic mobility shift assay (EMSA) was used to de-
termine the activation and DNA binding activity of Nrf2 in
the lungs in response to allergen challenge (Fig. 7 A). EMSA
analysis showed the increased binding of nuclear proteins
isolated from the lungs of OVA-challenged Nrf2 /  mice to
ARE consensus sequence relative to the OVA-challenged
Nrf2 /  mice or saline-challenged control mice. Supershift
analysis with anti-Nrf2 antibody also showed the binding of
Nrf2 to the ARE consensus sequence, suggesting the finding
that OVA challenge leads to the activation of Nrf2 in the
lungs of Nrf2 /  mice.
Immunoblot analysis showed (Fig. 7 B) an increased level
of Nrf2 in the lung nuclear extracts of Nrf2 /  OVA mice
compared with the saline-challenged counterpart, suggesting
the accumulation of Nrf2 in the lungs of wild-type mice in
response to allergen challenge. Increase of nuclear Nrf2 is
needed for the activation of ARE and the transcriptional in-
duction of various antioxidant genes.
Induction of antioxidant genes
There was a substantial and coordinated elevation in tran-
script levels of several antioxidant genes in the lungs of
Nrf2 /  OVA mice when compared with the OVA-chal-
lenged Nrf2-disrupted mice. The fold changes in mRNA of
various antioxidant genes as determined by real-time RT-
PCR were   GCL modifier subunit (  GCLm; 2.9 vs. 1.6),
GCLc (3.2 vs 1.7), glucose 6 phosphate dehydrogenase (G6PD;
6.3 vs. 4.6), GST  3 (6.2 vs. 1.7), GST p2 (3.4 vs. 1.6), HO-1
(2.8 vs. 1.5), SOD2 (5.7 vs 1.6), SOD3 (2.5 vs. 1.5), and glu-
tathione S-reductase (GSR; 3.9 vs. 1.5) in the lungs of Nrf2 / 
OVA (24 h after first challenge) and Nrf2 /  OVA mice, re-
spectively (Fig. 8). The magnitude of the induction of panel
of these antioxidant genes was considerably higher in Nrf2
wild-type than in Nrf2-disrupted mice, clearly showing an
association with the activation of Nrf2 in response to aller-
gen-induced lung inflammation.
Real-time PCR analysis showed the expression of Nrf2
in CD4  T cells and macrophages isolated from the lungs
of Nrf2 /  OVA mice (Fig. S3 A, available at http://www.
jem.org/cgi/content/full/jem.20050538/DC1). Quantita-
tive real-time RT-PCR revealed the increased expression of
Nrf2-regulated antioxidant genes, HO-1 (CD4  T cells, 2.5-
fold; macrophages, 11.2-fold), GCLc (CD4  T cells, 2.5-
fold; macrophages, 4.6-fold), and   GCLm (CD4  T cells,
2.5-fold; macrophages, 7.8-fold) in the CD4  T cells (Fig.
S3 B) and macrophages (Fig. S3 C) isolated from the lungs of
Nrf2 /  OVA mice when compared with the knock out
counterpart.
DISCUSSION
Our findings have indicated that Nrf2 is a critical determinant
of susceptibility to allergen-induced asthma. The role of oxi-
dative stress as a result of inflammation in the pathogenesis
and disease progression of asthma has gained increased atten-
tion in recent years. However, it has been unclear whether
Figure 7. Activation of Nrf2 in the lungs of OVA-challenged
Nrf2  /  mice. (A) EMSA was used to determine the activation of Nrf2 in 
the lungs of Nrf2 /  OVA mice. Equal amounts of nuclear extracts (10  g) 
prepared from lungs were incubated with radiolabeled ARE from the NQO1 
promoter and analyzed by EMSA. EMSA analysis showed the increased 
binding of nuclear proteins isolated from the lungs of OVA-challenged
Nrf2  /  mice to ARE sequence. The arrows indicate the supershifted band, 
the major band, and OCT1, respectively. (B) Level of nuclear Nrf2. Nrf2 level 
in nuclear extracts were determined by immunoblot analysis with anti-Nrf2 
antibody. (lanes 1 and 2) Saline-challenged Nrf2 /  and Nrf2  /  mice, 
respectively; (lanes 3 and 4) OVA-challenged Nrf2 /  and Nrf2  /  mice, 
respectively. The figure is representative of three experiments.ROLE OF NRF2 IN ASTHMA | Rangasamy et al. 54
the antioxidant status of the lung plays an important role in
susceptibility to asthma. The human studies to date have by
necessity been correlative and unable to address the issue of
causality (i.e., did oxidative stress contribute to or result from
allergic airway inflammation?). Furthermore, studies in animal
models using the exogenous administration of antioxidants or
antioxidant mimetics to decrease allergen-induced airway in-
flammation (23–25) suffer from concerns about nonspecific
effects of the compounds used. Here we used mice deficient
in a key regulatory transcription factor, Nrf2, to specifically
dissect the role of antioxidant responses in allergic airway in-
flammation. Our results demonstrate that Nrf2-mediated sig-
naling pathways serve to limit airway eosinophilia, mucus hy-
persecretion, and AHR in response to allergen challenge in a
relevant model of asthma. We documented the occurrence of
excess lung oxidative stress in the setting of Nrf2 deficiency,
which was considerably attenuated by the antioxidant NAC.
Collectively, these data provide compelling evidence for the
pathogenic role of oxidative stress in regulating the severity of
allergic airway inflammation and implicate a novel transcrip-
tion factor pathway in asthma pathogenesis.
Under normal conditions, Nrf2 is anchored in the cyto-
plasm by binding to an inhibitory protein called Keap1. In
response to oxidative stress, Nrf2 dissociates from Keap1 and
then binds to AREs in the upstream sequence of target genes
in association with several other proteins such as small maf
proteins, c-jun, ARE-binding protein 1, and CBP/p300 and
p160 family coactivators (26). In response to allergen chal-
lenge, there was an increased binding of nuclear proteins iso-
lated from the lungs of Nrf2 /  mice to probes containing
the ARE consensus sequence. This binding is presumably
caused by the interaction of nuclear proteins with the ARE,
particularly of Nrf2 in the lungs of allergen-exposed Nrf2 / 
mice, as confirmed by the supershift analysis with anti-Nrf2
antibody. The slight increase in the binding of nuclear pro-
teins from Nrf2 /  mice lung extracts to the ARE is proba-
bly caused by the interaction of proteins other than Nrf2.
Western blot analysis confirmed the nuclear accumulation of
Nrf2 in the lungs of OVA-challenged Nrf2 /  mice.
In response to allergen challenge, there was an increased
induction of an array of antioxidant genes in the lungs of
Nrf2 /  mice, including the genes (  GCLm and GCLc) in-
volved in GSH synthesis. GSH is the major intracellular thiol
antioxidant that acts directly as an ROS scavenger. The
GSH redox system (GSH and GSSG) plays a critical role in
determining intracellular redox balance and antioxidant
function (27). There was a 2.6-fold up-regulation of GSR in
the OVA-challenged wild-type mice in contrast to 1.3-fold
in the Nrf2-disrupted mice challenged with the allergen.
GSR uses NADPH for the regeneration of reduced glu-
tathione. G6PD, the enzyme involved in the regeneration of
NADPH, was also considerably induced in the wild-type
mice in response to allergen. Thus, our data indicate that
Nrf2 regulates several antioxidant genes that act in concert to
counteract oxidative stress and inflammation.
Our recent study (28) revealed the importance of  50
Nrf2-dependent antioxidant and cytoprotective genes in the
protection of lungs against cigarette smoke–induced emphy-
Figure 8. Real-time RT-PCR analysis of selected antioxidant genes in 
the lungs of OVA-challenged Nrf2 /  and Nrf2 /  mice. Real-time 
RT-PCR analysis showed increased levels of mRNA for genes such as   GCLm, 
GCLc, G6PD, GST  3, GST p2, HO-1, SOD2, SOD3, and GSR in the lungs of 
Nrf2 /  OVA compared with the lungs of Nrf2 /  OVA mice and the respec-
tive saline-challenged mice. Closed bar, Nrf2 /  mice; open bar, Nrf2 /  mice.JEM VOL. 202, July 4, 2005 55
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sema in Nrf2 wild-type mice. In the present study, to deter-
mine whether the increased airway inflammation in the
OVA-challenged Nrf2 /  mice was caused by the deficient
antioxidant levels in the lungs, we treated the animals with
NAC 7 d before the first OVA challenge. Pretreatment of
Nrf2 knockout mice with the antioxidant NAC greatly re-
duced eosinophil levels in the BAL fluid and inhibited the in-
filtration of inflammatory cells in the peribronchial and
perivascular region of the lungs, providing direct evidence that
the deficient antioxidant levels may increase the susceptibility
to airway inflammation in response to allergen challenge.
Given that a single antioxidant was able to greatly reduce eo-
sinophilia in the OVA-challenged Nrf2 /  mice, we believe
that the attenuation of the development of airway inflamma-
tion in Nrf2 wild-type mice is mediated by the coordinated
polygenic response of Nrf2-regulated antioxidant genes.
Genes for several other Nrf2-regulated antioxidant en-
zymes were also up-regulated to a greater extent in the mice
with functional Nrf2, including GST  3, GST p2, SOD2,
SOD3, and HO-1. Interestingly, polymorphisms in the pi
class GST locus are associated with asthma and homozygosity
for the GSTP1*Val allele has been shown to confer protec-
tion against toluene diisocyanate-induced asthma and airway
hyperresponsiveness (29). HO-1 has been shown to be a ma-
jor antioxidant enzyme in the lungs that protects against oxi-
dative stress, and adenoviral-mediated overexpression of HO-1
has been shown to confer protection against hyperoxic lung
injury in mice (30). The increased expression of this antioxi-
dant gene has been shown to inhibit TNF-  (31). SOD3 is
the major extracellular enzyme that counteracts ROS in
lungs. SOD3 is mainly associated with the connective tissue
matrix around vessels and airways in the lung, but is also
found in close proximity to airway and vascular smooth mus-
cle cells (32, 33). Intraperitoneal injection of the SOD mi-
metic reduced airway hyperresponsivenes in guinea pigs (34).
Disruption of the Nrf2 gene caused a greater increase in
the total number of inflammatory cells, predominantly eo-
sinophils, in BAL fluid relative to Nrf2 wild-type mice from
the first to third OVA challenges. OVA-challenged Nrf2-
deficient mice showed a 2.9-fold increase in the level of eo-
sinophils in the BAL fluid when compared with OVA-chal-
lenged Nrf2 wild-type mice. Furthermore, the increase in
asthmatic inflammation was reflected by severe extravasation
of eosinophils in the perivascular, peribronchial, and paren-
chymal tissues of the lungs of Nrf2 /  OVA mice. Disrup-
tion of the Nrf2 gene also caused higher numbers of neutro-
phils in the BAL in response to OVA challenge. A role for
neutrophils in the development of airway remodeling in se-
vere asthma has been suggested (35). In many cases of fatal
and nocturnal asthma, considerable increases in lung neutro-
phils have been observed (4). Eosinophils and neutrophils
generate reactive oxygen species that can potentially cause
destruction to host lung tissue and contribute to inflamma-
tory injury. The oxidative injury caused by eosinophils can
be substantial because of their enhanced capacity to generate
O2
  and H2O2 to levels higher than those produced by neu-
trophils (36). Thus, Nrf2 deficiency not only results in en-
hanced lung eosinophilia and neutrophilia, but also leads to
the reduced expression of antioxidant genes that would
counteract oxidative injury induced by these cells.
Oxidative stress can regulate cell recruitment to the lung
at multiple levels. First, ROS can activate NF- B, which is
known to induce the expression of proinflammatory factors
such as IL-8, RANTES, and the eosinophil attracting che-
mokine eotaxin-1 (7, 9, 22). Eotaxin-1 is a potent eosin-
ophil-attracting CC chemokine and plays a critical role in
inducing the accumulation of eosinophils in vivo (37). We
provide evidence for both enhanced NF- B activation and
eotaxin secretion in the setting of Nrf2 deficiency, support-
ing a model in which excess oxidative stress enhances cell re-
cruitment via NF- B–dependent chemokine secretion. Sec-
ond, oxidative stress has recently been shown to be
indirectly involved in the accumulation of eosinophils by
stimulating the synthesis of the eosinophil chemoattractant
5-oxo-6,8,11,14-eicosatetraenoic acid (38, 39). In future
studies, it will be interesting to determine the role of this and
other lipid mediators in eosinophil recruitment during aller-
gic inflammation. We observed a considerably increased
number of epithelial cells in the BAL fluid of third OVA-
challenged Nrf2-deficient mice than the Nrf2 wild-type mice
challenged with OVA. Damage to the epithelium by oxi-
dants released from inflammatory cells is a critical factor in
the pathogenesis of bronchial asthma (40), and the shedding
of epithelial cells is an important histological feature ob-
served in bronchial biopsy specimens from asthmatic patients
(41). Excessive apoptosis of epithelial cells may be a likely
mechanism responsible for damage to, and sloughing of, air-
way epithelial cells (40). Apoptosis is closely linked with ox-
idative stress and many agents that induce apoptosis are ei-
ther oxidants or stimulators of cellular oxidative metabolism
(42). The increased epithelial cells observed in the BAL fluid
of Nrf2-deficient mice may be caused by the shedding of
bronchial epithelial cells partly caused by excessive oxidative
stress occurring in the lungs after OVA challenge. The
mechanism by which Nrf2 protects against apoptosis in the
asthma model is a subject of a future investigation.
We found that the expression of the Th2 cytokines IL-4
and IL-13 was considerably higher in the BAL fluid of
OVA-challenged  Nrf2 /  mice compared with wild-type
controls. This helps explain the excess production of mucus
glycoproteins in Nrf2 /  mice given the strong link between
Th2 cytokines (especially IL-13) and goblet cell metaplasia
(43). Enhanced Th2 cytokine production appears to be
caused by allergen-driven Th2 cell sensitization in the con-
text of oxidative stress. We did not find evidence that Nrf2
acts in a T cell–intrinsic manner to repress IL-4 or IL-13 cy-
tokine gene expression or promoter activity. Enhanced Th2
sensitization has been reported in other models of oxidative
stress, including ozone inhalation (44, 45). The precise mo-
lecular mechanism of this requires further study, but may re-
flect the effects of oxidative stress on cells that influence Th
cell differentiation or on Th2 cell survival.ROLE OF NRF2 IN ASTHMA | Rangasamy et al. 56
The OVA-challenged Nrf2 /  mice showed increased
lung elastance and airway resistance under baseline conditions
compared with either knockout controls or OVA-challenged
Nrf2 /  mice. Interestingly, the percent increase in elastance
and resistance was notably higher in Nrf2 /  OVA compared
with Nrf2 /  OVA mice. Increased baseline resistance and
elastance suggest that Nrf2 deficiency could have resulted in a
chronic structural effect in the lung and it can also affect the
subsequent responsiveness to inhaled bronchoconstrictor.
The increased baseline elastance suggests the possibility that
there may be increased fluid in the lungs that obstructs venti-
lation. This inflammatory edema may also explain the nar-
rowed airways at baseline. Recent studies revealed the contri-
bution of several factors, including the lipid mediator
leukotriene and the Th2 cytokines IL-4 and IL-13, to airway
hyperreactivity. IL-4 and IL-13 are required for AHR induc-
tion through the induction of allergen-specific IgG1 and IgE
production, resulting in the activation of mast cells via anti-
gen/antibody complex–Fc receptor signaling (46, 47).
Altogether, these results provide a clear link between in-
flammation and the severity of asthma with the defect in sig-
naling mediated by the transcription factor Nrf2. Nrf2 is
activated in response to allergen challenge in the lungs of
wild-type mice, leading to the transcriptional induction of
many antioxidant genes that might provide resistance against
the development of asthma. Maintenance of a proper balance
between ROS production and antioxidant capability regu-
lated by Nrf2 is essential for the integrity and function of the
different cellular components of the lungs that determines
the outcome of allergen-induced asthma. Conversely, a lack
of responsiveness of the Nrf2 pathway confers susceptibility
to severe asthma because of allergen exposure in this model.
The identification of Nrf2 as a determinant of asthma sever-
ity has wide implications for lung diseases, where oxidative
stress and inflammation play an important role. Realizing the
importance of Nrf2 in the maintenance of antioxidant gene
regulation in lungs and its link with asthma from this work,
future studies on asthma susceptibility and variation in Nrf2
response should prove worthwhile.
MATERIALS AND METHODS
Animals and care. Nrf2-deficient CD1:ICR mice (SLC Japan Inc.) were
generated as previously described (48). Nrf2-deficient mice were generated
by replacing the b-ZIP region of the Nrf2 gene with the SV40 nuclear lo-
calization signal and  -galactosidase gene (48). Mice were genotyped for Nrf2
status by PCR amplification of genomic DNA extracted from the blood
(49). PCR amplification was performed using three different primers: 5 -
TGGACGGGACTATTGAAGGCTG-3  (sense for both genotypes), 5 -
CGCCTTTTCAGTAGATGGAGG-3  (antisense for WT Nrf2 mice), and
5 -GCGGATTGACCGTAATGGGATAGG-3  (antisense for LacZ).
Mice were fed an AIN-76A diet and water ad libitum and housed under
controlled conditions (23   2 C; 12-h light/dark periods). All experimental
protocols conducted on the mice were performed in accordance with the
standards established by the US Animal Welfare Acts, as set forth in Na-
tional Institutes of Health (NIH) guidelines and the Policy and Procedures
Manual of the Johns Hopkins University Animal Care and Use Committee.
Sensitization and challenge protocols. 8-wk-old male mice were sen-
sitized on day 0 by i.p. injection (100  l/mouse) with 20  g OVA com-
plexed with aluminum potassium sulfate. On day 14, mice were sensitized a
second time with 100  g OVA. On days 24, 26, and 28, the mice were
anesthetized by i.p. injection with 0.1 ml of a mixture of 10 mg/ml ket-
amine and 1 mg/ml xylazine diluted in sterile PBS and challenged with 200
 g OVA in 100  l of sterile PBS by intratracheal instillation. The control
groups received sterile PBS with aluminum potassium sulfate by the i.p.
route on days 0 and 14 and 0.1 ml of sterile PBS on days 24, 26, and 28.
Mice were killed at different time points after OVA challenge for BAL,
RNA isolation, histopathology, and for AHR measurements.
BAL fluid and phenotyping. Mice (n   8) were anesthetized with 0.3
ml of 65 mg/ml pentobarbital and the tracheas were cannulated. BAL fluid
was collected with 1 ml followed by 2  1 ml of sterile PBS containing 5
mM EDTA, 5 mM DTT, and 5 mM PMSF. The BAL fluid was immedi-
ately centrifuged at 1,500 g. The total cell count was measured, and
cytospin preparation (Shandon Scientific Inc.) was performed. Cells were
stained with Diff-Quick reagent (Baxter Dade), and a differential count of
300 cells was performed using standard morphological criteria (50).
Histochemistry. The lungs were inflated with 0.6 ml of 10% buffered
formalin, fixed for 24 h at 4 C, before histochemical processing. The whole
lung was embedded in paraffin, sectioned at a 5- m thickness, and stained
with H&E (n   6) for routine histopathology. Tissue sections were also
stained with PAS for the identification of stored mucosubstances within the
mucus goblet cells lining the main axial airways (proximal), as previously
described (51). The number of PAS-positive cells were counted on longitu-
dinal lung sections of the proximal airways. The percentage of PAS-positive
cells was determined by counting the mucus-positive cells and unstained
epithelial cells in the proximal airways under the microscope with a grid at
100 . Six animals were used for each treatment. The sum of the values of
five fields per slide for five slides is provided for each animal. The data are
expressed as means   SEM.
Immunohistochemical staining of eosinophils in the lungs. For de-
tection of eosinophils in tissues, the lung sections from the saline- and
OVA-challenged (72 h after third challenged) mice (n    6) were de-
parafinized and dehydrated in benzene and alcohol, respectively, and the
endogenous peroxidase activity was quenched with 0.6% H2O2 in 80%
methanol for 20 min. Sections were then digested with pepsin for 10 min
before blocking with 5% normal rabbit serum for 30 min at room tempera-
ture. Rat anti–mouse MBP-1 antibody (provided by J. Lee, Mayo Clinic,
Scottsdale, AZ) was then applied for 60 min, followed by a period of incu-
bation with rabbit anti–rat IgG–HRP conjugate for 60 min. HRP was visu-
alized with diaminobenzidine. Nuclei were then stained by application of
purified 2% methyl green for 2 min.
Intervention with NAC. Nrf2 /  and Nrf2 /  mice (n   6) were sensi-
tized with OVA according to the procedure described in the Sensitization
and challenge protocols section. Sensitized animals were randomly distrib-
uted into positive control (saline plus OVA), negative control (saline), and
NAC-treated (NAC plus saline or antigen) groups. NAC was dissolved in
distilled water (3 mmol/kg body weight, pH 7.0) and administered orally
by gavage (23) as a single daily dose for 7 d before challenge with the last
dose being given 2 h before OVA challenge. 24 h after challenge, BAL flu-
ids and lung tissues were harvested and analyzed as described in the BAL
fluid and phenotyping and Histochemistry sections. The experiment was
repeated twice.
Determination of lipid hydroperoxides and protein carbonyls in
the lungs. To quantify lipid hydroperoxides, lung tissues were homoge-
nized in 10 mM PBS containing 10  M cupric sulfate and incubated for 30
min at 37 C in a shaking water bath. 5 vol of methanol were added to the
lung homogenate, vortexed vigorously for 2 min, and centrifuged at 8,000 g
for 5 min. 0.9 ml of Fox reagent was added to 0.1 ml methanol extract and
incubated for 30 min at room temperature. The absorbance was read at 560JEM VOL. 202, July 4, 2005 57
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nM using a spectrophotometer. H2O2 was used as the standard. Data were
expressed as microgram of lipid hydroperoxide per milligram of protein us-
ing the molar extinction coefficient of 43,000 for hydroperoxides (52).
To determine the protein carbonyls, the lungs were homogenized in
10 mM Hepes buffer (137 mM NaCl, 4.6 mM KCl, 1.1 mM KH2PO4, 0.6
mM MgSO4, 1.1 mM EDTA, 5 mg/liter Tween 20, 1  M butylated hy-
droxytoluene, 0.5  g/ml leupeptine, 0.7  g/ml pepstatin, 0.5  g/ml apro-
tinin, and 40  g/ml PMSF) and centrifuged at 8,000 g for 10 min at 4 C.
Supernatant fractions were divided into two equal aliquots containing from
0.7 to 1 mg of protein each, precipitated with 10% TCA, and centrifuged at
8,000 g for 5 min at room temperature. One pellet was treated with 2.5 M
HCl, and the other was treated with an equal volume of 10 mM dinitro-
phenyl hydrazine in 2.5 M HCl at room temperature for 1 h. Samples were
reprecipitated with 10% TCA and subsequently with 1:1 ethanol/ethyl ace-
tate and again reprecipitated with 10% TCA. The pellets were dissolved in
20 mM phosphate buffer, pH 6.5 (containing 6 M guanidine hydrochlo-
ride), and left for 10 min at 37 C with general vortex mixing. Samples were
centrifuged at 6,000 g for 5 min and the clear supernatants were collected.
The difference in absorbance between DNPH-treated and the HCl control
was determined at 370 nM. Data were expressed as nanomole of carbonyl
groups/milligram of protein using the molar extinction coefficient of
21,000 for NADPH derivatives (53).
Measurement of airway responsiveness. On day 31 (96 h after the third
OVA challenge), mice (n   7) were anesthetized with sodium pentobarbital,
and their tracheas were cannulated via tracheostomy. The animals were venti-
lated as previously described (54) with a tidal volume of 0.2 ml at 2 Hz. 0.5
mg/kg body weight of succinylcholine was given i.p. to eliminate all respira-
tory efforts. Aerosol acetyl choline challenges were administered by nebuliza-
tion with a nebulizer (Aeroneb Pro; Aerogen, Inc.) modified to decrease the
dead space to 1 ml. Data were plotted as lung resistance and compliance at
baseline and in response to a 10-s challenge of 0.3 mg/ml acetylcholine.
Assay of T lymphocyte activation. To determine whether Nrf2 played
a T cell–intrinsic role in regulating Th2 cytokine gene expression, we isolated
CD4  T cells and splenocytes from the spleen of saline- and OVA-challenged
Nrf2 /  and Nrf2 /  mice, respectively and stimulated them for 24 h in the
absence or presence of anti-CD3 plus anti-CD28 antibodies or the calcium
ionophore A23187 plus the phorbol ester PMA, followed by analysis of cyto-
kine secretion by ELISA (Supplemental materials and methods, available at
http://www.jem.org/cgi/content/full/jem.20050538/DC1).
Luciferase promoter assay and Nrf2 overexpression. Reporter con-
structs containing the human IL-4 and IL-13 promoter regions linked to the
firefly luciferase gene were synthesized using standard techniques (pGL3 Ba-
sic; Promega). Promoter reporter constructs were cotransfected with an
Nrf2 expression vector into Jurkat T cells followed by analysis of reporter
gene expression using luminometry or endogenous gene expression by real-
time RT-PCR and ELISA (Supplemental materials and methods).
ELISA measurements of IL-4, IL-13, and eotaxin. To measure cyto-
kine levels, BAL fluid was collected from the lungs of each mouse (n   8)
with 0.7 ml PBS containing a cocktail of protease inhibitors and immedi-
ately centrifuged at 4 C for 5 min at 1,500 g. The supernatant was collected,
aliquoted, and frozen in liquid nitrogen. The levels of IL-4 and IL-3 in BAL
fluid, as well as in the supernatants from the splenocyte culture, were deter-
mined by ELISA using IL-4 and IL-13 quantikine ELISA kits. Eotaxin level
in BAL fluid was analyzed using a mouse eotaxin ELISA kit.
EMSA. EMSA was performed according to the previously published pro-
cedure (55).
Quantification of GSH and GSSG in lung tissue. The concentrations
of reduced and oxidized glutathiones in the lung tissues were measured using
BIOXYTECH GSH/GSSG-412 kit (Supplemental materials and methods).
Western blot analysis. Western blot analysis was performed according to
previously published procedures (28). In brief, 50  g of the nuclear proteins
isolated from the lungs of saline- and OVA-challenged (first) Nrf2 /  and
Nrf2 /  mice were separated by 10% SDS-PAGE (SDS-PAGE) and trans-
ferred to PVDF membrane. The PVDF membrane was incubated with
polyclonal rabbit anti-Nrf2 antibody followed by incubation with HRP-
conjugated secondary antibody and developed using an ECL chemilumines-
cence detection kit.
To determine the activation of NF- B, 15- g nuclear extracts isolated
from the lungs of saline- or OVA-challenged (first challenge) Nrf2 /  and
Nrf2–/– mice were subjected to SDS-PAGE, as described above. NF- B was
detected by incubating the blots with anti–NF- B p65 and anti–NF- B
p50 rabbit polyclonal antibodies. The blots were stripped and reprobed with
anti–lamin B1 antibody. Western blot was performed with protein extracts
from three different saline- or OVA-challenged Nrf2 /  and Nrf2–/– mice,
and band intensities of p65 and p50 subunits of NF- B of the three blots
were determined using the NIH Image-Pro Plus software. Values are repre-
sented as means   SEM.
P65/Rel A DNA binding activity. DNA binding activity of the p65/
Rel A subunit of NF- B was determined using Mercury TransFactor Kit
(BD Biosciences). An equal amount of nuclear extracts isolated from the lungs
were added to incubation wells precoated with the DNA-binding consensus
sequence. The presence of translocated p65/Rel A subunit was then assessed
by using the Mercury TransFactor kit according to manufacturer instructions.
Plates were read at 655 nm, and results were expressed as OD.
Quantitative real-time RT-PCR. Total RNA was extracted from the
lung tissues (n   3) with TRIzol reagent, and then used for first-strand
cDNA synthesis. Reverse transcription was performed with random hex-
amer primers and SuperScribe II reverse transcriptase. Using 100 ng cDNA
as a template, quantification was performed by a sequence detector (ABI
Prism 7000; Applied Biosystems) using the TaqMan 5  nuclease activity
from the TaqMan Universal PCR Master Mix, fluorogenic probes, and oli-
gonucleotide primers. The copy numbers of cDNA targets were quantified
by the point during cycling when the PCR product was first detected. The
PCR primers and probes detecting GST   3 (available from GenBank/
EMBL/DDBJ under accession no. X65021) were designed based on the se-
quences reported in GenBank with the Primer Express software, version 2.0
(Applied Biosystems), as follows: GST   3 forward primer, 5 -CCTG-
GCAAGGTTACGAAGTGA-3 ;  GST   3 reverse primer 5 -CAG-
TTTCATCCC GTCGATCTC-3 ; GST  3 probe FAM 5 -CTGATGT-
TCCAGCAAGTGCCC-3  TAMRA. For the rest of the genes, including
GAPDH control, the (Applied Biosystems) assay on-demand kits containing
the respective primers were used. TaqMan assays were repeated in triplicate
samples for each of nine selected antioxidant genes (  GCLm, GCLc, GSR,
GST  3, GST p2, G6PD, SOD2, SOD3, and HO-1) in each lung sample.
The mRNA expression levels for all samples were normalized to the level
of the housekeeping gene GAPDH.
Statistical analysis. Results are shown as means   SEM. Differences be-
tween groups were determined by Student’s t test using the InStat program
(Graph Pad Software, Inc.) and were considered statistically significant for
P   0.05.
Online supplemental material. Procedures for the analysis of GSH and
GSSG, isolation of lung CD4  T cells and macrophages, T lymphocyte ac-
tivation assay, construction of Nrf2 expression vector and IL-4 and IL-13
promoter constructs, RT-PCR to analyze the expression of Nrf2 gene, and
antibodies and reagents used are available in Supplemental materials and
methods. Fig. S1 shows the percentage of GSH increase and GSH/GSSG
ratios, respectively, in the lungs of saline- and OVA-challenged Nrf2 /  and
Nrf2 /  mice. Fig. S2 shows the Nrf2 overexpression in mouse Hepa cells
(A), overexpression of Nrf2 and Nrf2-dependent antioxidant genes in the
Jurkat cell line (B), the effect of Nrf2 overexpression on IL-13 promoter ac-ROLE OF NRF2 IN ASTHMA | Rangasamy et al. 58
tivity (C), and IL-13 protein level (D) in the Jurkat cell line. Fig. S3 shows
the expression of Nrf2 and Nrf2-dependent antioxidant genes (HO-1,
GCLc, and   GCLm) in the lung CD4  T cells and macrophages isolated
from the OVA-challenged Nrf2 /  and Nrf2 /  mice. Table S1 shows the
Th2 cytokine response of the spleenocytes of OVA-challenged Nrf2 /  and
Nrf2 /  mice. Table S2 shows the Th2 cytokine response of the CD4  T
cells isolated from the spleen of saline-challenged Nrf2 /  and Nrf2 / 
mice. Online supplemental material is available at http://www.jem.org/
cgi/content/full/jem.20050538/DC1.
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